Clinical Trial Update: Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Icariin for bipolar disorder with co-occurring substance use disorders has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Substance Use Disorder

Drugs mentioned

• Icariin (icariin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Substance Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-04-19